These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1943979)
1. Topical corticosteroids. Med Lett Drugs Ther; 1991 Nov; 33(857):108-10. PubMed ID: 1943979 [No Abstract] [Full Text] [Related]
2. Clobetasol--a potent new topical corticosteroid. Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267 [No Abstract] [Full Text] [Related]
3. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants. Cherian MP; AbdulJabbar M Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195 [No Abstract] [Full Text] [Related]
4. [Emovate in pediatric practice. A Swiss study on a new local corticosteroid]. Graber W; Miescher A; Schneider HJ Ther Umsch; 1983 May; 40(5):449-53. PubMed ID: 6346567 [No Abstract] [Full Text] [Related]
5. Comparative study of the efficacy of topical corticosteroid: five locally made and one brand name creams. Puavilai S; Krisadaphong P; Leenutaphong V; Asawanonda P; Akaraphan R; Ploysangham T; Ruangkarnchanasetr S; Noppakun N; Charuwichitratana S; Kulthanan K; Huiprasert P; Tresukosol P; Ophaswongse S J Med Assoc Thai; 2002 Jul; 85(7):789-99. PubMed ID: 12296411 [TBL] [Abstract][Full Text] [Related]
9. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone. Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704 [TBL] [Abstract][Full Text] [Related]
10. Cushing's syndrome from topical glucocorticoids. Teelucksingh S; Bahall M; Coomansingh D; Suite M; Bartholomew C West Indian Med J; 1993 Jun; 42(2):77-8. PubMed ID: 8367969 [TBL] [Abstract][Full Text] [Related]
11. [Fluticasone propionate--a new inhalation steroid for the treatment of bronchial asthma]. Lange P; Vestbo J Ugeskr Laeger; 1996 Jan; 158(4):439-44. PubMed ID: 8638310 [No Abstract] [Full Text] [Related]
14. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay. Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415 [TBL] [Abstract][Full Text] [Related]
15. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid]. Zimmermann R; Faure M; Claudy A Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883 [TBL] [Abstract][Full Text] [Related]
16. Cushing's syndrome caused by topical steroid therapy for psoriasis. Abma EM; Blanken R; De Heide LJ Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372 [TBL] [Abstract][Full Text] [Related]
17. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094 [TBL] [Abstract][Full Text] [Related]
18. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. Gilbertson EO; Spellman MC; Piacquadio DJ; Mulford MI J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):318-21. PubMed ID: 9486706 [TBL] [Abstract][Full Text] [Related]
20. [A Cochrane report compares inhaled steroids for asthma. No big differences between the most common preparations]. Foucard T; Skoogh BE Lakartidningen; 2003 Apr; 100(15):1346-7. PubMed ID: 12739405 [No Abstract] [Full Text] [Related] [Next] [New Search]